New
Image

01.08.2025
Teplizumab benefits, remission and eating disorders and the power of r...
We take a look at some of the exciting diabetes research developments announced in July, and what the fin...
customer support
customer support
We take a look at some of the exciting diabetes research developments announced in July, including how teplizumab targets type 1 diabetes and understanding the risk of eating disorders for people taking part in type 2 diabetes remission programmes.
Read more